196 related articles for article (PubMed ID: 4366321)
1. [Synacthen-depot in dermatology (author's transl)].
Dubois-Ferrière G; Hunziker N; Orusco M
Dermatologica; 1974; 148(2):65-71. PubMed ID: 4366321
[No Abstract] [Full Text] [Related]
2. [Possibilities and limitations of the use of Synacthen Depot Ciba in dermatology].
Ormea F; Muscardin L; Rusciani L; Garcovich A
Minerva Med; 1970 Sep; 61(78):4261-7. PubMed ID: 4325284
[No Abstract] [Full Text] [Related]
3. [Therapy of skin- and venereal diseases. Review of the literature 1969].
Walther H
Dtsch Med J; 1970 Jun; 21(12):870-6 passim. PubMed ID: 4259633
[No Abstract] [Full Text] [Related]
4. Intermittent tetracosactrin-depot therapy in dermatology.
Khan SA; Smith AF
Br J Dermatol; 1970 Apr; 82(4):389-96. PubMed ID: 4315091
[No Abstract] [Full Text] [Related]
5. [Use of synthetic ACTH in the therapy of dermatologic diseases].
Schuppli R
Dermatologica; 1969; 139(4):243-53. PubMed ID: 4392894
[No Abstract] [Full Text] [Related]
6. [Experience in using a zinc-corticotropin suspension in the therapy of certain dermatoses].
Borisenko KK; Glozman VN
Vestn Dermatol Venerol; 1974 May; 48(5):78-80. PubMed ID: 4365447
[No Abstract] [Full Text] [Related]
7. [Synacthen depot in the treatment of some dermatological diseases].
Mazurkiewicz W; D abrowska H
Przegl Dermatol; 1972; 59(3):377-82. PubMed ID: 4340580
[No Abstract] [Full Text] [Related]
8. Low-Molecular-Weight Heparins as Immunomodulators in Dermatology Practice.
Solak B
Am J Ther; 2016; 23(6):e1911-e1917. PubMed ID: 25853237
[TBL] [Abstract][Full Text] [Related]
9. [Advantages and disadvantages of steroid therapy in skin diseases].
Steigleder GK
Klin Monbl Augenheilkd; 1966; 148(6):800-10. PubMed ID: 5987288
[No Abstract] [Full Text] [Related]
10. [The introduction of 9,9-dioxopromethazine (Prothanon) into the treatment of skin diseases in hospitalized patients].
Nitzschner H
Pharmazie; 1970 Feb; 25(2):111-3. PubMed ID: 4393059
[No Abstract] [Full Text] [Related]
11. [On the use of a new emulsion of corticosteroids in the treatment of a series of dermatitis cases].
Scarpa C; Ferrea E
Minerva Dermatol; 1968 Oct; 43(10):484-8. PubMed ID: 4237977
[No Abstract] [Full Text] [Related]
12. [The oral corticosteroid treatment of "benign" dermatoses].
Jadassohn W; Musso E
Munch Med Wochenschr; 1967 Jul; 109(29):1539-41. PubMed ID: 4232480
[No Abstract] [Full Text] [Related]
13. [Tiapride in dermatology].
Michel F
Sem Hop; 1979 Feb 8-15; 55(5-6):305-7. PubMed ID: 219545
[TBL] [Abstract][Full Text] [Related]
14. [CORTICOTHERAPY BY INTRAMUSCULAR INJECTIONS IN CORTICO-SENSITIVE CHRONIC DERMATOSES (PEMPHIGUS, LUPUS ERYTHEMATOSUS, DUHRING'S DISEASE, ETC.)].
GRUPPER C
Bull Soc Fr Dermatol Syphiligr; 1963; 70():383-6. PubMed ID: 14079068
[No Abstract] [Full Text] [Related]
15. [Clinical experience with a new antihistaminic].
Wolfram S
Wien Med Wochenschr; 1967 Sep; 117(38):868-70. PubMed ID: 4385553
[No Abstract] [Full Text] [Related]
16. [Therapy of chronic refractory skin diseases with synthetic ACTH, Cortrocin-depot].
Hayakawa M
Hifuka Kiyo; 1970 Feb; 65(1):51-61. PubMed ID: 4321317
[No Abstract] [Full Text] [Related]
17. [Dermatology and climatic therapy with special reference to the Davos climate].
Brenn H
Dermatologica; 1969; 139(4):278-85. PubMed ID: 4246136
[No Abstract] [Full Text] [Related]
18. USE OF CYPROHEPTADINE AND CYPROHEPTADINE-DEXAMETHASONE COMBINATION IN DERMATOLOGIC DISORDERS.
GRAYSON LD; SHAIR HM
Clin Med (Northfield); 1964 Apr; 71():713-6. PubMed ID: 15446150
[No Abstract] [Full Text] [Related]
19. [Problems of climatotherapy in dermatoses. Indications and chances of success].
Borelli S
Munch Med Wochenschr; 1969 Aug; 111(35):1709-17. PubMed ID: 4241287
[No Abstract] [Full Text] [Related]
20. [Clinical experience with a new corticosteroid for topical use: formocortal].
Buzzoni A; Guarneri B
G Ital Dermatol Minerva Dermatol; 1969 Dec; 44(12):673-6. PubMed ID: 4243641
[No Abstract] [Full Text] [Related]
[Next] [New Search]
